Uganda has reported one more lab-confirmed Ebola infection, which involves a 23-year-old woman who is a healthcare worker in Mubende, one of the outbreak's hot spots, according to an update yesterday from the World Health Organization (WHO) Uganda office.
The report reveals encouraging investments but also persistent COVID-19 vaccine inequity and a nearly vacant pipeline for products to treat or prevent emerging pathogens that have pandemic potential.
Uganda's health ministry yesterday reported that Ebola has spread to Jinja district in the southeastern part of the country (see Google Maps image below).
At a World Health Organization (WHO) briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said Uganda's government is making progress in its battle against Ebola, but he raised concerns about case detections outside the main hot spots.
A study of US patients aged 0 to 20 years hospitalized for COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in 2020 and 2021 shows that 22% had a neurologic condition, including 9% with life-threatening illness.
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
Flu activity is starting to rise in parts of the Northern Hemisphere, including Europe and North America, the World Health Organization (WHO) said in its latest global flu update, which covers data through Oct 16.
Two new infections an 9 new deaths raise the outbreak total to 130 cases, 43 of them fatal.
Officials are now reporting 128 lab-confirmed cases, up from 109, and the case-fatality rate is 28%.
Officials will evaluate 3 Sudan Ebola vaccine candidates, and healthcare workers are already testing some new treatment options.
